HEALTHCARE TRIANGLE INC (HCTI)
US42227W2070 - Common Stock
Overall HCTI gets a fundamental rating of 1 out of 10. We evaluated HCTI against 37 industry peers in the Health Care Technology industry. HCTI may be in some trouble as it scores bad on both profitability and health. HCTI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
HCTI had negative earnings in the past year.
HCTI had a positive operating cash flow in the past year.
In multiple years HCTI reported negative net income over the last 5 years.
In the past 5 years HCTI reported 4 times negative operating cash flow.
1.2 Ratios
The Return On Assets of HCTI (-208.83%) is worse than 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -208.83% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of HCTI (25.14%) is worse than 83.33% of its industry peers.
In the last couple of years the Gross Margin of HCTI has declined.
HCTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.14% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HCTI has been increased compared to 1 year ago.
HCTI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -12.28, we must say that HCTI is in the distress zone and has some risk of bankruptcy.
HCTI has a worse Altman-Z score (-12.28) than 91.67% of its industry peers.
The Debt to FCF ratio of HCTI is 1.14, which is an excellent value as it means it would take HCTI, only 1.14 years of fcf income to pay off all of its debts.
HCTI's Debt to FCF ratio of 1.14 is amongst the best of the industry. HCTI outperforms 80.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.14 | ||
| Altman-Z | -12.28 |
ROIC/WACCN/A
WACC18.09%
2.3 Liquidity
A Current Ratio of 0.29 indicates that HCTI may have some problems paying its short term obligations.
The Current ratio of HCTI (0.29) is worse than 91.67% of its industry peers.
HCTI has a Quick Ratio of 0.29. This is a bad value and indicates that HCTI is not financially healthy enough and could expect problems in meeting its short term obligations.
HCTI's Quick ratio of 0.29 is on the low side compared to the rest of the industry. HCTI is outperformed by 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 24.99% over the past year.
HCTI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -55.75%.
The Revenue has been growing slightly by 1.94% on average over the past years.
EPS 1Y (TTM)24.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.08%
Revenue 1Y (TTM)-55.75%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Sales Q2Q%-68.98%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
HCTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HCTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, HCTI is valued cheaper than 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.92 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
HCTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HEALTHCARE TRIANGLE INC
NASDAQ:HCTI (12/20/2024, 8:16:19 PM)
0.82
-0.01 (-0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners2.01%
Inst Owner Change67.5%
Ins Owners0.54%
Ins Owner Change0%
Market Cap4.65M
Analysts82.86
Price TargetN/A
Short Float %2.04%
Short Ratio0.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.28 | ||
| P/FCF | 4.92 | ||
| P/OCF | 4.9 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.18
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.17
FCFY20.33%
OCF(TTM)0.17
OCFY20.39%
SpS2.92
BVpS-0.32
TBVpS-0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -208.83% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.14% | ||
| FCFM | 5.7% |
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
F-Score5
Asset Turnover3.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.14 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 | ||
| Altman-Z | -12.28 |
F-Score5
WACC18.09%
ROIC/WACCN/A
Cap/Depr(3y)106.37%
Cap/Depr(5y)169.41%
Cap/Sales(3y)5.38%
Cap/Sales(5y)6.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.08%
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-55.75%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Sales Q2Q%-68.98%
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y109.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.08%
OCF growth 3YN/A
OCF growth 5YN/A